MUX McEwen Inc.
Gold and Silver Ores · NYSE · SEC CIK 314203 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY45.1%
TTM net income YoY472.8%
TTM EPS YoY352.2%
Revenue 3-yr CAGR21.2%
Net income 3-yr CAGR—
Margins
Gross margin30.2%
Operating margin20.6%
Net margin18.4%
FCF margin—
EBITDA margin32.8%
Returns
ROE7.6%
ROA5.2%
ROIC (approx.)7.6%
Asset turnover0.28x
Leverage & solvency
Liabilities / assets30.9%
Debt / equity0.19x
Current ratio1.34x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio1.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $197.55M | $174.48M |
| Cost of revenue | $122.76M | $113.31M |
| Gross profit | $47.56M | $30.93M |
| SG&A expense | $26.70M | $17.16M |
| Operating income | $2.65M | -$50.57M |
| Interest expense | — | $3.03M |
| Pretax income | $6.95M | -$46.74M |
| Income tax | -$27.48M | -$3.05M |
| Net income | $34.43M | -$43.69M |
| EBITDA | $30.50M | -$19.71M |
| EPS (basic) | 0.64 | -0.86 |
| EPS (diluted) | 0.59 | -0.86 |
| Weighted avg. shares (diluted) | 65.56M | 51.02M |
| Banking | ||
| Net interest income | -$7.22M | -$4.59M |
| Balance sheet | ||
| Cash & equivalents | $51.02M | $13.69M |
| Short-term investments | $21.11M | $1.62M |
| Receivables | $9.22M | — |
| Inventory | $26.84M | $18.11M |
| Current assets | $107.89M | $41.19M |
| Total assets | $820.22M | $664.62M |
| Current liabilities | $63.81M | $47.69M |
| Short-term debt | — | $12.00M |
| Long-term debt | $126.17M | $40.00M |
| Total debt | $126.17M | $52.00M |
| Total liabilities | $273.98M | $169.65M |
| Shareholders' equity | $546.24M | $494.98M |
| Net debt | $75.15M | $38.31M |
| Shares outstanding | 55.52M | 53.05M |
| Cash flow statement | ||
| Operating cash flow | $6.87M | $29.45M |
| Investing cash flow | -$48.03M | -$58.05M |
| Financing cash flow | $78.73M | $19.20M |
| Depreciation & amortization | $27.85M | $30.86M |
| Stock-based compensation | $1.30M | $900,000 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.